Congrats to Katalin Susztak, MD, PhD, on election to the National Academy of Medicine! A Colton-affiliated researcher, she’s transformed kidney disease research—mapping risk genes, revealing cellular energy defects, and advancing precision medicine for IgA nephropathy. https://bit.ly/49tSJ60

Penn physician–scientist and Colton-affiliated researcher David Fajgenbaum, MD, MBA, MSc joins the Huberman Lab podcast to discuss how repurposed drugs—many already FDA-approved—can unlock new treatments for #autoimmunity, rare diseases, and beyond.

🎧 Listen: www.hubermanlab.com/episode/davi...

Join us Nov. 18 for the Colton Consortium Virtual Speaker Series! Hear from David Hafler, MD, FANA (@yaleschoolofmed.bsky.social) a leader in #neuroimmunology, on the gut–brain axis in homeostasis and disease. Registration required: bit.ly/HaflerNov18

E. John Wherry, PhD, reflected on a conversation with his friend—and new Nobel laureate—Fred Ramsdell, PhD, about the future of #autoimmunity research. Ramsdell’s advice to “stay focused on foundational research” is guiding the direction of Penn’s Colton Center for Autoimmunity. bit.ly/471uuKQ

Last week, Dr. Wherry showed Good Morning Philadelphia around Penn Medicine's new collaborative research hub for #immunology, #immunehealth, and #autoimmunity, including the new home of the Penn Colton Center for Autoimmunity. Watch the interview: https://www.fox29.com/video/1707836

Have you registered yet for next week's session (9/16, 11AM ET) of the #ColtonConsortium Virtual Speaker Series featuring Mark Anderson, MD, PhD (USCF + @ucsfdc.bsky.social)? Dr. Anderson will address "Dissection of #Autoimmunity Through Outliers." Registration required: bit.ly/AndersonSept16

We're thrilled to share space in Penn Medicine's new collaborative research hub for #immunology, #immunehealth, and #autoimmunity — working with remarkable labs and leaders to advance scientific breakthroughs that benefit patients' lives.

Katalin Susztak, MD, PhD, and team developed #AI tools and datasets—like the SISKA atlas and CellSpectra—to map 70+ kidney cell types. This advances precision medicine with the potential to reveal new insights into immune-mediated kidney disease. bit.ly/4mSH0lk

Don't miss the next installment (9/16, 11AM ET) of the #ColtonConsortium Virtual Speaker Series featuring Mark Anderson, MD, PhD (UCSF + @ucsfdc.bsky.social), a leader in #diabetes and #autoimmunity research. Registration required: bit.ly/AndersonSept16

Earlier this year, the Colton Center for Autoimmunity at @pennmedicine.bsky.social launched two new Centers of Excellence to advance autoimmune diagnostics and treatment—deepening its impact through the @coltonconsortium.bsky.social. Learn more about the missions of HIT-AI and CREATE: bit.ly/4kRTJCT

Congratulations to Sahily Reyes-Esteves, MD, PhD (@sahilyreyes.bsky.social), Assistant Professor of Neurology and Colton Center awardee, and our other Penn Medicine (@pennmedicine.bsky.social) colleagues on being selected for a McCabe Fund Award! 🏆

Genetic screening may have unlocked a path for treating the severe inflammation associated with many immune diseases by regulating one protein’s role in helping another protein control cell acidity, according to recent research published in Cell by the @minerlab.bsky.social. bit.ly/43Hw6HK

Big news out of @pennmedicine.bsky.social: @davidfajgenbaum.bsky.social, @jbrandmdphd.bsky.social, and colleagues have identified Oligocentric Castleman Disease (OligoCD)—the first new Castleman subtype in 45 years. This discovery has the potential to reshape diagnosis and care for thousands.

150+ experts came together at the 2025 Penn Colton Center for #Autoimmunity Symposium to discuss breakthroughs in #ImmuneHealth and spotlight Penn’s leadership, future headquarters, and innovations in autoimmunity research and #PrecisionMedicine.

Read more: www.coltonconsortium.org/blog/2025-pe...